EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)VergleichsstudieOpen Access · CC BY 4.0

Acute skin toxicity and cosmesis outcome in non-metastatic breast cancer patients treated with ultrahypofractionated radiotherapy: a randomized controlled phase II clinical trial comparing proton versus photon radiotherapy

Thanaporn Sarsitthithum, Chonnipa Nantavithya, Chawalit Lertbutsayanukul, Kitwadee Saksornchai iD

Journal of Radiation Research · 24.07.2026 · 67 (4) · 609-617

DOI: 10.1093/jrr/rrag037 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Radiation Research, online erschienen am 25.05.2026. Verfasst von Thanaporn Sarsitthithum und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Oncology, Department of Radiology, King Chulalongkorn Memorial Hospital, RamaIV Road, Pathum Wan, Bangkok 10330, Thailand. Hauptthemen laut MEDLINE: Breast Neoplasms, Photons, Proton Therapy, Radiodermatitis. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 1-week photon radiotherapy schedule of 26 Gy in 5 fractions is as safe and effective as the standard 3-week schedule of 40 Gy in 15 fractions for adjuvant local radiotherapy in early stage breast cancer. Proton radiotherapy offers dosimetric advantages by reducing heart and lung dose but may be associated with increased acute skin toxicity, and the acute toxicity of ultra-hypofractionated proton therapy remains unknown. In this randomized trial, non-metastatic breast cancer patients were assigned to receive either proton or photon radiotherapy at a dose of 26 Gy in 5 fractions delivered on alternate days, with the aim of comparing acute skin toxicity between the two modalities. Of 140 eligible patients, 72 were included in this interim analysis, with 36 patients in each treatment arm. The highest observed toxicity was grade 2 radiation dermatitis, which occurred in one patient in the proton arm. The incidence of acute radiation dermatitis was significantly higher in the proton arm than in the photon arm (97.2% vs. 75%, P = 0.006), while no significant differences were observed in other acute toxicities. Patients treated with photon radiotherapy demonstrated better cosmetic outcomes (41.7% vs. 13.9%, P = 0.007) and higher satisfaction scores (80.6% vs. 58.3%, P = 0.04) compared with those treated with proton radiotherapy. At a median follow-up of 9 months (IQR: 6–11), no locoregional recurrence was observed in either treatment arm. This interim analysis indicates that ultra-hypofractionated proton therapy is associated with a higher incidence of mild acute radiation dermatitis, whereas photon radiotherapy results in superior cosmetic outcomes and patient satisfaction, with longer follow-up required to determine long-term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPhotonsProton TherapyRadiodermatitisHumansFemaleTreatment OutcomeMiddle AgedAgedAdultDose Fractionation, Radiation

Stichwörter der Autor:innen

breast cancerbreast radiotherapyhypofractionatedproton therapy

Autor:innen und Institutionen

  • Division of Radiation Oncology, Department of Radiology, King Chulalongkorn Memorial Hospital, RamaIV Road, Pathum Wan, Bangkok 10330, Thailand.
  • Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, RamaIV Road, Pathum Wan, Bangkok 10330, Thailand.

ORCID-Profile: Kitwadee Saksornchai

Zitieren

APA

Sarsitthithum, T., Nantavithya, C., Lertbutsayanukul, C., & Saksornchai, K. (2026). Acute skin toxicity and cosmesis outcome in non-metastatic breast cancer patients treated with ultrahypofractionated radiotherapy: a randomized controlled phase II clinical trial comparing proton versus photon radiotherapy. Journal of Radiation Research, 67(4), 609-617. https://doi.org/10.1093/jrr/rrag037

Vancouver

Sarsitthithum T, Nantavithya C, Lertbutsayanukul C, Saksornchai K. Acute skin toxicity and cosmesis outcome in non-metastatic breast cancer patients treated with ultrahypofractionated radiotherapy: a randomized controlled phase II clinical trial comparing proton versus photon radiotherapy. Journal of Radiation Research. 2026;67(4):609-617. doi:10.1093/jrr/rrag037

BibTeX
@article{Sarsitthithum2026,
  author = {Sarsitthithum, Thanaporn and Nantavithya, Chonnipa and Lertbutsayanukul, Chawalit and Saksornchai, Kitwadee},
  title = {Acute skin toxicity and cosmesis outcome in non-metastatic breast cancer patients treated with ultrahypofractionated radiotherapy: a randomized controlled phase II clinical trial comparing proton versus photon radiotherapy},
  journal = {Journal of Radiation Research},
  year = {2026},
  volume = {67},
  number = {4},
  pages = {609--617},
  doi = {10.1093/jrr/rrag037}
}
Kostenlos starten →